Legis Daily

TRANSPLANT Act of 2020

USA116th CongressHR-4764| House 
| Updated: 12/14/2020
Doris O. Matsui

Doris O. Matsui

Democratic Representative

California

Cosponsors (52)
Raúl M. Grijalva (Democratic)Stephanie N. Murphy (Democratic)Don Young (Republican)Joyce Beatty (Democratic)David J. Trone (Democratic)Ed Case (Democratic)Sheila Jackson Lee (Democratic)Thomas P. Tiffany (Republican)Ilhan Omar (Democratic)Pete Aguilar (Democratic)Terri A. Sewell (Democratic)Bobby L. Rush (Democratic)Jimmy Panetta (Democratic)Eric Swalwell (Democratic)Greg Walden (Republican)Madeleine Dean (Democratic)Angie Craig (Democratic)Thomas R. Suozzi (Democratic)Anthony G. Brown (Democratic)Michael Waltz (Republican)Greg Stanton (Democratic)Alan S. Lowenthal (Democratic)Gus M. Bilirakis (Republican)Kurt Schrader (Democratic)Henry C. "Hank" Johnson (Democratic)Matt Cartwright (Democratic)Harley Rouda (Democratic)G. K. Butterfield (Democratic)Ann Wagner (Republican)Richard Hudson (Republican)Jahana Hayes (Democratic)Josh Harder (Democratic)Betty McCollum (Democratic)Denny Heck (Democratic)Joe Neguse (Democratic)Cynthia Axne (Democratic)Sean Casten (Democratic)Diana DeGette (Democratic)James P. McGovern (Democratic)Adam Smith (Democratic)Julia Brownley (Democratic)Tom Emmer (Republican)Peter Welch (Democratic)Brian K. Fitzpatrick (Republican)Charlie Crist (Democratic)Josh Gottheimer (Democratic)Cathy McMorris Rodgers (Republican)Alcee L. Hastings (Democratic)Ted Budd (Republican)Robert B. Aderholt (Republican)Chellie Pingree (Democratic)Grace F. Napolitano (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020 This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies. Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells. In addition, the Government Accountability Office must examine various issues related to the regenerative medicine workforce.

Bill Text Versions

View Text
5 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 18, 2019
Introduced in House
Oct 18, 2019
Referred to the House Committee on Energy and Commerce.
Oct 21, 2019
Referred to the Subcommittee on Health.
Sep 9, 2020
Ordered to be Reported by Voice Vote.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
Sep 23, 2020

Latest Companion Bill Action

S 116-4672
Introduced in Senate
Sep 29, 2020
Placed on the Union Calendar, Calendar No. 449.
Sep 29, 2020
Reported by the Committee on Energy and Commerce. H. Rept. 116-549.
Sep 29, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Sep 29, 2020
Considered under suspension of the rules. (consideration: CR H4996-4998)
Sep 29, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 4764.
Sep 29, 2020
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Sep 30, 2020
Considered as unfinished business. (consideration: CR H5089-5090)
Sep 30, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 414 - 0 (Roll no. 211). (text: CR 09/29/2020 H4996)
View Vote
Sep 30, 2020
Motion to reconsider laid on the table Agreed to without objection.
Oct 1, 2020
Received in the Senate, read twice.
Dec 11, 2020
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7450-7451)
Dec 11, 2020
Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7450-7451)
Dec 11, 2020
Measure laid before Senate by unanimous consent. (consideration: CR S7450-7451)
Dec 14, 2020
Message on Senate action sent to the House.
  • October 18, 2019
    Introduced in House


  • October 18, 2019
    Referred to the House Committee on Energy and Commerce.


  • October 21, 2019
    Referred to the Subcommittee on Health.


  • September 9, 2020
    Ordered to be Reported by Voice Vote.


  • September 9, 2020
    Committee Consideration and Mark-up Session Held.


  • September 23, 2020

    Latest Companion Bill Action

    S 116-4672
    Introduced in Senate


  • September 29, 2020
    Placed on the Union Calendar, Calendar No. 449.


  • September 29, 2020
    Reported by the Committee on Energy and Commerce. H. Rept. 116-549.


  • September 29, 2020
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • September 29, 2020
    Considered under suspension of the rules. (consideration: CR H4996-4998)


  • September 29, 2020
    DEBATE - The House proceeded with forty minutes of debate on H.R. 4764.


  • September 29, 2020
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • September 30, 2020
    Considered as unfinished business. (consideration: CR H5089-5090)


  • September 30, 2020
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 414 - 0 (Roll no. 211). (text: CR 09/29/2020 H4996)
    View Vote


  • September 30, 2020
    Motion to reconsider laid on the table Agreed to without objection.


  • October 1, 2020
    Received in the Senate, read twice.


  • December 11, 2020
    Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7450-7451)


  • December 11, 2020
    Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7450-7451)


  • December 11, 2020
    Measure laid before Senate by unanimous consent. (consideration: CR S7450-7451)


  • December 14, 2020
    Message on Senate action sent to the House.

Health

Related Bills

  • S 116-4672: TRANSPLANT Act of 2020
  • HR 116-3520: Stem Cell Therapeutic and Research Reauthorization Act of 2019
Advisory bodiesBlood and blood diseasesCell biology and embryologyCongressional oversightGovernment studies and investigationsHealth programs administration and fundingMedical researchOrgan and tissue donation and transplantationResearch administration and funding

TRANSPLANT Act of 2020

USA116th CongressHR-4764| House 
| Updated: 12/14/2020
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020 This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies. Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells. In addition, the Government Accountability Office must examine various issues related to the regenerative medicine workforce.

Bill Text Versions

View Text
5 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 18, 2019
Introduced in House
Oct 18, 2019
Referred to the House Committee on Energy and Commerce.
Oct 21, 2019
Referred to the Subcommittee on Health.
Sep 9, 2020
Ordered to be Reported by Voice Vote.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
Sep 23, 2020

Latest Companion Bill Action

S 116-4672
Introduced in Senate
Sep 29, 2020
Placed on the Union Calendar, Calendar No. 449.
Sep 29, 2020
Reported by the Committee on Energy and Commerce. H. Rept. 116-549.
Sep 29, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Sep 29, 2020
Considered under suspension of the rules. (consideration: CR H4996-4998)
Sep 29, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 4764.
Sep 29, 2020
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Sep 30, 2020
Considered as unfinished business. (consideration: CR H5089-5090)
Sep 30, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 414 - 0 (Roll no. 211). (text: CR 09/29/2020 H4996)
View Vote
Sep 30, 2020
Motion to reconsider laid on the table Agreed to without objection.
Oct 1, 2020
Received in the Senate, read twice.
Dec 11, 2020
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7450-7451)
Dec 11, 2020
Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7450-7451)
Dec 11, 2020
Measure laid before Senate by unanimous consent. (consideration: CR S7450-7451)
Dec 14, 2020
Message on Senate action sent to the House.
  • October 18, 2019
    Introduced in House


  • October 18, 2019
    Referred to the House Committee on Energy and Commerce.


  • October 21, 2019
    Referred to the Subcommittee on Health.


  • September 9, 2020
    Ordered to be Reported by Voice Vote.


  • September 9, 2020
    Committee Consideration and Mark-up Session Held.


  • September 23, 2020

    Latest Companion Bill Action

    S 116-4672
    Introduced in Senate


  • September 29, 2020
    Placed on the Union Calendar, Calendar No. 449.


  • September 29, 2020
    Reported by the Committee on Energy and Commerce. H. Rept. 116-549.


  • September 29, 2020
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • September 29, 2020
    Considered under suspension of the rules. (consideration: CR H4996-4998)


  • September 29, 2020
    DEBATE - The House proceeded with forty minutes of debate on H.R. 4764.


  • September 29, 2020
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • September 30, 2020
    Considered as unfinished business. (consideration: CR H5089-5090)


  • September 30, 2020
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 414 - 0 (Roll no. 211). (text: CR 09/29/2020 H4996)
    View Vote


  • September 30, 2020
    Motion to reconsider laid on the table Agreed to without objection.


  • October 1, 2020
    Received in the Senate, read twice.


  • December 11, 2020
    Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7450-7451)


  • December 11, 2020
    Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7450-7451)


  • December 11, 2020
    Measure laid before Senate by unanimous consent. (consideration: CR S7450-7451)


  • December 14, 2020
    Message on Senate action sent to the House.
Doris O. Matsui

Doris O. Matsui

Democratic Representative

California

Cosponsors (52)
Raúl M. Grijalva (Democratic)Stephanie N. Murphy (Democratic)Don Young (Republican)Joyce Beatty (Democratic)David J. Trone (Democratic)Ed Case (Democratic)Sheila Jackson Lee (Democratic)Thomas P. Tiffany (Republican)Ilhan Omar (Democratic)Pete Aguilar (Democratic)Terri A. Sewell (Democratic)Bobby L. Rush (Democratic)Jimmy Panetta (Democratic)Eric Swalwell (Democratic)Greg Walden (Republican)Madeleine Dean (Democratic)Angie Craig (Democratic)Thomas R. Suozzi (Democratic)Anthony G. Brown (Democratic)Michael Waltz (Republican)Greg Stanton (Democratic)Alan S. Lowenthal (Democratic)Gus M. Bilirakis (Republican)Kurt Schrader (Democratic)Henry C. "Hank" Johnson (Democratic)Matt Cartwright (Democratic)Harley Rouda (Democratic)G. K. Butterfield (Democratic)Ann Wagner (Republican)Richard Hudson (Republican)Jahana Hayes (Democratic)Josh Harder (Democratic)Betty McCollum (Democratic)Denny Heck (Democratic)Joe Neguse (Democratic)Cynthia Axne (Democratic)Sean Casten (Democratic)Diana DeGette (Democratic)James P. McGovern (Democratic)Adam Smith (Democratic)Julia Brownley (Democratic)Tom Emmer (Republican)Peter Welch (Democratic)Brian K. Fitzpatrick (Republican)Charlie Crist (Democratic)Josh Gottheimer (Democratic)Cathy McMorris Rodgers (Republican)Alcee L. Hastings (Democratic)Ted Budd (Republican)Robert B. Aderholt (Republican)Chellie Pingree (Democratic)Grace F. Napolitano (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-4672: TRANSPLANT Act of 2020
  • HR 116-3520: Stem Cell Therapeutic and Research Reauthorization Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Advisory bodiesBlood and blood diseasesCell biology and embryologyCongressional oversightGovernment studies and investigationsHealth programs administration and fundingMedical researchOrgan and tissue donation and transplantationResearch administration and funding